SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

AGM Statement

2 Dec 2016 07:00

RNS Number : 7607Q
James Halstead PLC
02 December 2016
 

 

2 December 2016

JAMES HALSTEAD PLC

 

Chairman's Statement to the Annual General Meeting

 

 

James Halstead plc, the commercial flooring company, is holding its 101st AGM today at 12.00 noon at which the Chairman, Mr Geoffrey Halstead, will make the following statement: 

As is customary, I would like to give you an update on trading now that we are five months into the current financial year.

 

The fall in the value of Sterling following the referendum vote of June has contributed to increased margins on our overseas sales, increased competitiveness and positive growth although it is still early days. There are, of course, off-setting price pressures from the lower value of sterling but overall the benefit is positive.

It was noted by the CEO in the results announced on 30 September 2016 that revenues in the UK market were below last year and this has continued. Whilst we note no slippage in market share, the market is lower than last year with the best estimate of this reduction being 4 -5 %. Nevertheless, these were all known factors that our management team have factored into budgets and targets.

In recent weeks there has been significant upward pressure on the pricing of plasticiser, one of our key raw materials, due to a suspension of production following an explosion at one of BASF's European plants. BASF are not our main supplier and we have, to date, accessed appropriate volumes elsewhere in the market however their failure to supply has raised industry prices and introduced supply chain delays and shortages. This may well continue into the second half of the financial year.

 

In conclusion, trading to date has been challenging and making progress against the comparative half-year will be difficult. Our cash balances have grown and continue to be solid underpinning the 8.5p dividend to be proposed today - an increase of 8.2% on that of last year and continuing our long history of dividend growth.  I remain confident in the prospects of the Company going forward.

 

 

 

- ends -

Enquiries:

 

James Halstead:

Telephone: 0161 767 2500

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Hudson Sandler:

Telephone: 020 7796 4133

Nick Lyon

Panmure Gordon (Nomad and Joint Brokers):

Telephone: 020 7886 2500

Ben Thorne

Andrew Potts

Arden (Joint Broker):

Telephone: 020 7614 5900

Chris Hardie

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUAOBRNWAURAA
Date   Source Headline
16th Mar 20153:46 pmRNSNotice of Interim Results
3rd Mar 20153:00 pmRNSTotal Voting Rights
30th Jan 20157:00 amRNSPre Close Trading Statement
6th Jan 20154:11 pmRNSBlocklisting Interim Review
6th Jan 201511:21 amRNSTotal Voting Rights
5th Dec 20147:00 amRNSAGM Statement
3rd Nov 20147:00 amRNSTotal Voting Rights
24th Oct 20143:24 pmRNSAnnual Financial Report
1st Oct 20149:25 amRNSTotal Voting Rights
1st Oct 20147:00 amRNSPreliminary Results
27th Aug 20147:00 amRNSNotice of Preliminary Results
31st Jul 20147:00 amRNSPre-Close Trading Statement
21st Jul 20143:50 pmRNSDirectors' Shareholdings
17th Jul 20144:51 pmRNSDirectors exercise of share options
1st Jul 20147:00 amRNSBlocklisting Interim Review
1st Jul 20147:00 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTotal Voting Rights
1st May 201411:10 amRNSTotal Voting Rights
31st Mar 20147:00 amRNSInterim Results
3rd Feb 20147:00 amRNSPre Close Trading Statement
20th Jan 20149:40 amRNSPurchase of own shares and directors' dealings
6th Jan 20144:30 pmRNSBlocklisting Interim Review
6th Dec 20137:00 amRNSAGM Statement
4th Nov 201311:00 amRNSTotal Voting Rights
28th Oct 20135:25 pmRNSAnnual Financial Report
28th Oct 20134:18 pmRNSDirectors exercise of share options
4th Oct 201312:40 pmRNSTotal Voting Rights
1st Oct 20137:00 amRNSPreliminary Announcement of Audited Results
23rd Sep 201312:55 pmRNSNotice of Preliminary Results
31st Jul 20137:00 amRNSPre-close Trading Statement
16th Jul 201312:00 pmRNSBlocklisting Interim Review
21st Jun 20134:35 pmRNSPrice Monitoring Extension
2nd May 201311:10 amRNSTotal Voting Rights
28th Mar 20137:00 amRNSInterim Results
1st Feb 201311:15 amRNSNotice of Interim Results Date Change
31st Jan 20134:00 pmRNSTotal Voting Rights
31st Jan 20137:00 amRNSPre-close Trading Statement
10th Jan 201311:00 amRNSIssue of Equity and Total Voting Rights
7th Jan 20139:00 amRNSBlocklisting Interim Review
11th Dec 20127:00 amRNSBonus Issue
7th Dec 20124:40 pmRNSSecond Price Monitoring Extn
7th Dec 20124:35 pmRNSPrice Monitoring Extension
7th Dec 20127:00 amRNSAGM Statement
3rd Dec 20127:00 amRNSTotal Voting Rights
1st Nov 20127:00 amRNSTotal Voting Rights
23rd Oct 20127:00 amRNSAnnual Financial Report
1st Oct 20127:00 amRNSPreliminary Audited Results
3rd Sep 20127:00 amRNSTotal Voting Rights
30th Jul 20127:00 amRNSPre-close Trading Statement
2nd Jul 20129:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.